<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
PROGENICS PHARMACEUTICALS, INC.
-------------------------------
(Exact name of registrant as specified in its charter)
Delaware 13-3379479
- - - - ------------------------------------- ------------------------------------
(State of incorporation (I.R.S. Employer Identification No.)
or organization)
777 Old Saw Mill River Road
Tarrytown, New York
(Address of principal
executive offices) 10591
------------------------------------
(Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
- - - - -----------------------------------------------------------------
Title of each class Name of each exchange on which
to be so registered each class is to be registered
- - - - ------------------- -----------------------------------
None N/A
- - - - ------------------- -----------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
- - - - -----------------------------------------------------------------
Common Stock, par value $.0013 per share
----------------------------------------
(Title of class)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
For a description of the Common Stock, par value $.0013 per share, of
the Registrant being registered hereunder, reference is made to the information
under the heading "Description of Capital Stock" on pages 57 and 58 of the
Registrant's Preliminary Prospectus dated October 7, 1996 forming a part of the
Registrant's Registration Statement on Form S-1 (Reg. No. 333-13627) as filed
with the Securities and Exchange Commission on October 7, 1996 (Exhibit 1
hereto). The aforementioned description is hereby incorporated by reference
herein and made a part of this registration statement.
ITEM 2. EXHIBITS.
- - - - ------ ---------
1. Certificate of Incorporation, as amended, of
Progenics Pharmaceuticals, Inc. (incorporated
herein by reference to Exhibit 3.1 of the
Registration Statement on Form S-1 of
Progenics Pharmaceuticals, Inc. (Reg. No.
333-13627)).
2. By-laws of Progenics Pharmaceuticals, Inc.
(incorporated herein by reference to Exhibit
3.2 of the Registration Statement on Form S-1
of Progenics Pharmaceuticals, Inc. (Reg. No.
333-13627)).
3. Form of Registration Rights Agreement
(incorporated by reference to Exhibit 10.1 of
the Registration Statement on Form S-1 of
Progenics Pharmaceuticals, Inc. (Reg. No.
333-13627)).
2
<PAGE>
SIGNATURE
---------
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Progenics Pharmaceuticals, Inc.
---------------------------------
(Registrant)
/s/ Robert A. McKinney
Dated: October 22, 1996 By: --------------------------------
Name: Robert A. McKinney
Title: Vice President, Finance and
Operations
3
